DNA vaccines : types, advantages, and limitations /
Saved in:
Imprint: | New York : Nova Biomedical Books, c2011. |
---|---|
Description: | 1 online resource. |
Language: | English |
Series: | Immunology and immune system disorders Immunology and immune system disorders. |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11146065 |
MARC
LEADER | 00000cam a2200000 i 4500 | ||
---|---|---|---|
001 | 11146065 | ||
005 | 20210426223411.1 | ||
006 | m o d | ||
007 | cr ||||||||||| | ||
008 | 110322s2011 nyua ob 001 0 eng | ||
010 | |a 2019714320 | ||
016 | 7 | |a 015875048 |2 Uk | |
019 | |a 779844104 |a 1066598908 |a 1081262926 | ||
020 | |a 9781620810453 |q ebook | ||
020 | |a 162081045X | ||
020 | |z 1613244444 |q hardcover : alk. paper | ||
020 | |z 9781613244449 |q hardcover : alk. paper | ||
035 | |a (OCoLC)952772313 |z (OCoLC)779844104 |z (OCoLC)1066598908 |z (OCoLC)1081262926 | ||
035 | 9 | |a (OCLCCM-CC)952772313 | |
040 | |a DLC |b eng |e rda |c DLC |d UMMBL |d OCLCO |d N$T |d YDXCP |d OCLCF |d NLGGC |d D6H |d MERUC |d AGLDB |d ZCU |d VTS |d COCUF |d TOF |d AU@ |d WYU |d REC |d VT2 |d STF |d K6U | ||
049 | |a MAIN | ||
050 | 0 | 0 | |a QR189.5.D53 |
060 | 1 | 0 | |a QW 805 |
072 | 7 | |a MED |x 071000 |2 bisacsh | |
245 | 0 | 0 | |a DNA vaccines : |b types, advantages, and limitations / |c Erin C. Donnelly and Arthur M. Dixon, editors. |
264 | 1 | |a New York : |b Nova Biomedical Books, |c c2011. | |
300 | |a 1 online resource. | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
490 | 1 | |a Immunology and immune system disorders | |
504 | |a Includes bibliographical references and index. | ||
588 | |a Description based on print version record. | ||
505 | 0 | |a DNA VACCINES: TYPES, ADVANTAGES AND LIMITATIONS ; IMMUNOLOGY AND IMMUNE SYSTEM DISORDERS ; DNA VACCINES: TYPES, ADVANTAGES AND LIMITATIONS ; Contents ; Preface ; Novel Carrier Adjuvant for DNA Vaccination ; Abstract ; 1. Introduction ; 2. Immunology of DNA Vaccines: Mode of Action and Immune Response Induction ; 3. Barriers in DNA Vaccine Delivery and Possible Modes to Overcome these Barriers ; 4. Novel Strategies for DNA Delivery ; 4.1. Lipid Based Carrier Adjuvants for DNA Vaccination ; 4.1.1. Liposomes ; 4.1.2. Virosomes. | |
505 | 8 | |a 4.2. Polymers and Polymeric Carriers Systems 4.2.1. Polyethylenimine ; 4.2.2. Polylysine ; 4.2.3. Chitosan ; 4.2.4. Dendrimers ; 5. Concluding Remark and Future Prospects ; References ; Improving the Immunogenicity of DNA Vaccines: A Nano-Sized Task? ; Abstract ; Introduction ; Improving Immunogenicity of Plasmid DNA Vaccines ; Routes of Delivery of Plasmid DNA Vaccines ; Physical Delivery Systems of Plasmid DNA Vaccines ; Needle-Free Delivery Methods ; Expression Optimization ; Cytokines ; Delivery Vectors for DNA Vaccines ; Bacterial Vectors ; Viral Vectors. | |
505 | 8 | |a DNA and RNA Replicons Nano-Sized Vehicles for Gene Delivery ; Inorganic to Biomaterial -- Past to Future ; Size Determines the Fate of Particles ; Conclusion ; References ; Novel Delivery Strategies for DNA ; Abstract ; I. Introduction ; II. Optimization of Immunogenicity of DNA Vaccines ; 2.1. Choice of Targets and Expression Plasmid for DNA Vaccines ; 2.2. Selection of High Expression Plasmids for DNA Vaccines ; 2.3. Codon Optimization for Higher Gene Expression ; 2.4. Adjuvant Choice for DNA Vaccines ; III. DNA Delivery Strategies ; 3.1. Invasive Delivery. | |
505 | 8 | |a 3.1.1. Needle Injection 3.1.2. In Vivo Electroporation ; 3.1.3. Tattoo Gun Delivery ; 3.2. Non-Invasive Topical Delivery Method ; 3.2.1. Tape Stripping ; 3.2.2. Nanopatch Delivery ; 3.2.3. Nano-Particle Mediated Delivery ; 3.3. Viral-Mediated DNA Delivery Systems ; 3.4. Non-Viral Gene Delivery Systems ; 3.5. Novel Delivery Methods ; 3.5.1. Laser Mediated Delivery ; 3.5.2. Ultrasound Mediated Delivery System ; III. Future Directions ; References ; Recent Advances in DNA Vaccines ; Abstract ; Introduction ; DNA Vaccines X Traditional Vaccine Approaches ; Components of a DNA Vaccine. | |
505 | 8 | |a How DNA Vaccines Work Delivery Methods ; Advantages X Limitations ; Strategies to Enhance Immunogenicity of DNA Vaccines ; Modifications of Plasmid Basic Design ; Delivery Methods ; Target to Dendritic Cells ; Improved Immunization Protocols ; Adjuvants ; Conclusion ; References ; Co-Administration of Gamma Interferon Gene with DNA Vaccine Expressing Duck Hepatitis B Virus (DHBV) Proteins Enhances Therapeutic Efficacy of DNA-Based Immunization in Chronic Virus Carriers ; Abstract ; Introduction ; Materials and Methods ; Animals ; DNA Immunization. | |
650 | 0 | |a DNA vaccines. |0 http://id.loc.gov/authorities/subjects/sh95007398 | |
650 | 2 | |a Vaccines, DNA. |0 https://id.nlm.nih.gov/mesh/D019444 | |
650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
650 | 7 | |a DNA vaccines. |2 fast |0 (OCoLC)fst00886608 | |
655 | 4 | |a Electronic books. | |
655 | 0 | |a Electronic books. | |
655 | 7 | |a Electronic books. |2 lcgft | |
700 | 1 | |a Donnelly, Erin C. | |
700 | 1 | |a Dixon, Arthur M. | |
776 | 0 | 8 | |i Print version: |t DNA vaccines |d New York : Nova Biomedical Books, c2011. |z 9781613244449 (hardcover : alk. paper) |w (DLC) 2011012604 |
830 | 0 | |a Immunology and immune system disorders. |0 http://id.loc.gov/authorities/names/n2010183470 | |
903 | |a HeVa | ||
929 | |a oclccm | ||
999 | f | f | |i 82203055-22b6-5e2b-8c99-0f0fd23b0efd |s 55bf8988-b3ce-5879-990f-5967fe68d1fa |
928 | |t Library of Congress classification |a QR189.5.D53 |l Online |c UC-FullText |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=439182 |z eBooks on EBSCOhost |g ebooks |i 12440318 |